Victor M.G. Chaltiel
Founder, Redhills Ventures™ LLC

Redhills Ventures LLC, is a private family investment vehicle with a focus primarily in healthcare services, information technology and real estate.

Mr. Chaltiel has 30+ years of experience as an executive in the healthcare industry and currently serves as Founder and Chairman of HealthDataInsights Inc. (www.healthdatainsights.com) the industry leader in healthcare claims integrity: fraud, waste, abuse, errors, and overpayments identification and recoupment solutions. Mr. Chaltiel is also Chairman of Trustifi Corporation (www.trustifi.com), a company focused on digital content authentication solutions, including USPS electronic postmarks®.

Before founding Redhills Ventures and for five years, from August 1994 to August 1999, Mr. Chaltiel served as Chairman of the Board and Chief Executive Officer of publicly held Total Renal Care Holdings, Inc now Davita (NYSE: DVA), the nation's second largest provider of renal dialysis services with annual revenues then well in excess of $1 billion.

Before joining DVA, he served for more than five years (1989-1994) as Chairman and CEO of then publicly-listed Total Pharmaceutical Care, a leading provider of home healthcare and infusion therapy services, which was subsequently acquired by Abbey, and is now known as Apria Healthcare Group. From 1985 to 1988, Mr. Chaltiel served as President, Chief Operating Officer and a Director of Salick Health Care, Inc., a then publicly-held company focusing on the development of outpatient cancer and dialysis treatment centers, which was later acquired by Zeneca (NYSE: ZEN).

Prior to May 1985, Mr. Chaltiel was associated for 18 years with Baxter International, Inc (NYSE: BAX), holding numerous corporate and divisional management positions, including Corporate Group Vice President, responsible for International operations and five domestic divisions (revenues then well in excess of $1 Billion); President of Baxter's Artificial Organs (Dialysis) Division; Vice President of its International Division; Area Managing Director for Europe and President of its French operations. During his tenure with Baxter, Mr. Chaltiel was instrumental in the successful development and worldwide commercialization of Continuous Ambulatory Peritoneal Dialysis (CAPD), currently the leading home dialysis treatment modality. He was honored by the National Kidney Foundations of Northern and Southern California, as well as those in New York and the Capital Area.

Mr. Chaltiel is active in several community and non-profit organizations, including the United Way (Million Dollar Roundtable). He is also a member of the Board of Directors of the American Committee of the Weizmann Institute of Science (ACWIS) as well as Chairman of the Board of Trustees of The Adelson Educational Campus serving grades pre-k through 12.

Mr. Chaltiel is a graduate of the Ecole Superieure des Sciences Economiques et Commerciales (Essec, Paris, France), and holds a master's degree in business administration from the Harvard Business School.

Email: vchaltiel@redhillsventures.com